New Vaccine, Old False-Claim Playbook - NewsGuard's Reality Check
Daily Fact Check from NewsGuard AI
Did Alaska report more votes than it has adult citizens in the 2026 midterm elections, proving widespread voter fraud?
Anti-Vaxxers Attack Moderna’s New Flu Vaccine With an Old Weapon
By John Gregory
What’s happening: Prominent anti-vaccine activists are deploying their classic trope of misrepresenting a U.S. government database to falsely portray a new flu vaccine as dangerous.
Context: Pharmaceutical company Moderna’s new flu vaccine, sold under the brand name mFluvisa, is the first flu shot available in the U.S. using the messenger RNA technology used by the COVID-19 vaccines made by Moderna and Pfizer. MFluvisa was approved by the U.S. Food and Drug Administration in August for people aged 50 and older and became available at U.S. pharmacies in mid-September.
As Johns Hopkins University explained in an August 2026 article, mRNA vaccines trigger the body’s immune system by instructing the body to produce a small piece of a virus, and can be developed more quickly than traditional vaccines. That means that mRNA shots can be matched to flu strains closer to the beginning of flu season.
Here We Go Again: The anti-vaxxers’ attack on mFluvisa is based on reports made to the U.S. Vaccine Adverse Events Reporting System (VAERS). This federal database is designed to detect possible safety issues with vaccines by collecting unverified reports of any adverse events that purportedly happened after vaccination. The first VAERS reports naming...
Read Full Story: https://news.google.com/rss/articles/CBMiggFBVV95cUxNNnNrR3BOLWNobGhFZm1vRl9f...